Rankings
▼
Calendar
ENGN Q1 2026 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena
ENGN
enGene Holdings Inc.
$359M
Q1 2026 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
$31M
Net Income
$30M
EPS (Diluted)
$0.44
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$337M
Total Liabilities
$56M
Stockholders' Equity
$282M
Cash & Equivalents
$37M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$102,000
+100.0%
Operating Income
$31M
-$27M
+217.2%
Net Income
$30M
-$25M
+220.9%
← Q4 2025
All Quarters